{"id":45907,"date":"2021-12-24T06:28:10","date_gmt":"2021-12-24T11:28:10","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=45907"},"modified":"2021-12-24T00:30:58","modified_gmt":"2021-12-24T05:30:58","slug":"abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907","title":{"rendered":"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market"},"content":{"rendered":"<p>Technavio has reported that <strong>Abbie Inc (NYSE: ABBV)<\/strong> and Aurobindo Pharma Ltd could benefit the female infertility drug market growth. Technavio expects North America to play a vital role in increasing the market.<\/p>\n<p>Calculations show that the region could account for 35% growth. Despite this, Europe and Asia will experience faster growth. Between 2020 and 2025, the industry could grow by $538.69 million. The growth will be driven by increased infertility, the high cost of non-therapeutic measures, and adverse outcomes.<\/p>\n<p>The report issued a detailed outlay of this market&#8217;s growth by synthesizing studies and collecting data from various sources and by analyzing several vital parameters. Moreover, it provides a comprehensive analysis of vendors\u2019 trends and the possible trends that will affect the market.<\/p>\n<p><b>Technavio examined the route of administration\u00a0<\/b><\/p>\n<p>Technavio managed to analyze the market using geography, that is, Asia, North America, and Europe. It also looks into the administration route, that is, vaginal, oral, parenteral. Parenteral drugs could have a higher market share.<\/p>\n<p>In addition,\u00a0 the companies named in the report include Dr. Reddy&#8217;s Lab Limited, Aurobindo, Lupin Ltd, Abbvie Inc, among others.<\/p>\n<p>The drugs to be authorized during this period include peptides. The drug contains the peptide hormone that imitates the effects physiologically brought about by gonadotropins.<\/p>\n<p><b>Analysts expect growth in the industrial Ethernet market<\/b><\/p>\n<p>According to another report by Technavio, the Industrial Ethernet market could rise by $29.39 billion from 2020 to 2025. The market ratio affected by the Ethernet industry issues an analysis of the utilized and future methods and strategies adopted by its sellers and the challenges incurred.<\/p>\n<p>The report analyzes that this portion of the industry holds the most significant share in 2020 and extends even after the forecasted period. However, the increased price of raw materials in this industry might challenge this prediction.<\/p>\n<p><b>\u00a0<\/b>AlphaCentric Robotics and Automation Fund recently acquired companies such as Vuzix Corp, ABB, Bioxcel Therapeutic Inc while selling Nano Dimension and\u00a0 THK company, among other investments.<\/p>\n<p>Since the third quarter, the company had funded 40 stocks worth 44million dollars. The new company acquiring\u2019s in the quarterly report creates an impressive footprint in the Industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Technavio has reported that Abbie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd could benefit the female infertility drug market growth. Technavio expects North America to [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":45908,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[16130,3644,16128,16129,16131,9644],"stock_ticker":[14234],"class_list":["post-45907","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-abbie-inc-nyse-abbv","tag-abbv","tag-abbv-news","tag-abbv-stock","tag-aurobindo-pharma-ltd","tag-nyse-abbv","stock_ticker-abbv","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Technavio has reported that Abbie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd could benefit the female infertility drug market growth. Technavio expects North America to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-24T11:28:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"466\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market\",\"datePublished\":\"2021-12-24T11:28:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907\"},\"wordCount\":365,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg\",\"keywords\":[\"Abbie Inc (NYSE: ABBV)\",\"ABBV\",\"ABBV News\",\"ABBV Stock\",\"Aurobindo Pharma Ltd\",\"NYSE: ABBV\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907\",\"name\":\"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg\",\"datePublished\":\"2021-12-24T11:28:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg\",\"width\":700,\"height\":466},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907","og_locale":"en_US","og_type":"article","og_title":"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market - Wall Street PR","og_description":"Technavio has reported that Abbie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd could benefit the female infertility drug market growth. Technavio expects North America to [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2021-12-24T11:28:10+00:00","og_image":[{"width":700,"height":466,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market","datePublished":"2021-12-24T11:28:10+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907"},"wordCount":365,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg","keywords":["Abbie Inc (NYSE: ABBV)","ABBV","ABBV News","ABBV Stock","Aurobindo Pharma Ltd","NYSE: ABBV"],"articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907","url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907","name":"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg","datePublished":"2021-12-24T11:28:10+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/12\/Female-Infertility-Drugs.jpg","width":700,"height":466},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyse-abbv-and-aurobindo-pharma-ltd-could-benefit-from-a-growth-in-the-female-infertility-drugs-market-45907#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"AbbVie Inc (NYSE: ABBV) and Aurobindo Pharma Ltd Could Benefit From a Growth in the Female Infertility Drugs Market"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/45907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=45907"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/45907\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/45908"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=45907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=45907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=45907"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=45907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}